Vascular anomalies associated with hepatic shunting

Table 5 Hereditary hemorrhagic telangiectasia hepatic involvement treatment considerations

HHT hepatic involvement treatment considerations
Symptom control: Iron deficiency, heart failure, esophageal varices
Anti-VEGF antibodies (i.e., bevacizumab)
Hepatic arterial embolization: Typically, an adult palliative option
Liver transplant: In setting of extensive hepato-biliary necrosis or heart failure

HHT: Hereditary hemorrhagic telangiectasia.